Choose a country to view content specific to your location
Choose a country to view content specific to your location
The glomerular basement membrane (GBM) is a specialized structure with a significant role in maintaining the glomerular filtration barrier. Anti–GBM antibody disease (also known as Goodpasture’s Syndrome) is a rare autoimmune disorder in which autoantibodies target and cause damage to the GMB of the kidney. The primary target of these autoantibodies is collagen type IV which is present in the lung and the glomerulus of the nephron. Rapid diagnostic testing using native or recombinant GBM to detect the presence of GBM autoantibodies is critical in the management of this rare, life-threatening disease.
Contact us to learn more about Meridian’s molecular or immunoassay reagent portfolio. We want to hear from you!
Have questions about a product? Want to learn more about Meridian’s molecular or immunoassay reagent portfolio? We want to hear from you!
By submitting your information in this form, you agree that your personal information may be stored and processed in any country where we have facilities or service providers, and by using our “Contact Us” page you agree to the transfer of information to countries outside of your country of residence, including to the United States, which may provide for different data protection rules than in your country. The information you submit will be governed by our Privacy Statement.
| Type |
|---|
| Format |
| Host/Source |
| Isotype |
| Tested Apps |
| Unit |
| Catalog |
| Buffer |
| Immunogen |
| COFA Description |
| COFA Notes |
| Recombination |
| SDS |
| COA |
| Product Information Sheet |
| Request Sample |
